Peter Svennilson - 16 Jun 2021 Form 4 Insider Report for Oric Pharmaceuticals, Inc. (ORIC)

Reporting relationship: Director, 10%+ Owner
Issuer ticker: ORIC
Reported as of: 16 Jun 2021
Net transaction value: $0
SEC form: 4
Accepted by SEC: 17 Jun 2021, 19:49:47 UTC
Prior SEC filing: 24 Jun 2021
Source filing: View source filing
Reporting owner signature: /s/ Dominic Piscitelli, attorney-in-fact

Key filing fact

Peter Svennilson filed Form 4 for Oric Pharmaceuticals, Inc. (ORIC) on 17 Jun 2021.

Key facts

This page summarizes Peter Svennilson's Form 4 filing for Oric Pharmaceuticals, Inc. (ORIC).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 17 Jun 2021, 19:49.

Change

Previous filing in this sequence was filed on 24 Jun 2021.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ORIC transaction Derivative

Stock Option (right to buy)

Award

Transaction value: $0
Shares: +16,625
Change %
Price: $0.000000
Shares after: 16,625
Date: 16 Jun 2021
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 16,625
Exercise price: $19.03
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

One hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) June 16, 2022 or (ii) the business day prior to the next annual meeting of the Issuer's stockholders that occurs following the date of grant.

SEC remarks

Exhibit 24 - Power of Attorney